001     875439
005     20210130004932.0
024 7 _ |a 10.1002/adhm.201901820
|2 doi
024 7 _ |a 2192-2640
|2 ISSN
024 7 _ |a 2192-2659
|2 ISSN
024 7 _ |a 2128/25111
|2 Handle
024 7 _ |a altmetric:81816420
|2 altmetric
024 7 _ |a pmid:32378355
|2 pmid
024 7 _ |a WOS:000530631000001
|2 WOS
037 _ _ |a FZJ-2020-02034
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Stengelin, Elena
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Bone Scaffolds Based on Degradable Vaterite/PEG‐Composite Microgels
260 _ _ |a Weinheim
|c 2020
|b Wiley-VCH
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1592764808_26605
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Vaterite, a metastable modification of calcium carbonate, embedded in a flexible microgel packaging with adjustable mechanical properties, functionality, and biocompatibility, provides a powerful scaffolding for bone tissue regeneration, as it is easily convertible to bone‐like hydroxyapatite (HA). In this study, the synthesis and physical analysis of a packaging material to encapsulate vaterite particles and osteoblast cells into monodisperse, sub‐millimeter‐sized microgels, is described whereby a systematic approach is used to tailor the microgel properties. The size and shape of the microgels is controlled via droplet‐based microfluidics. Key requirements for the polymer system, such as absence of cytotoxicity as well as biocompatibility and biodegradability, are accomplished with functionalized poly(ethylene glycol) (PEG), which reacts in a cytocompatible thiol–ene Michael addition. On a mesoscopic level, the microgel stiffness and gelation times are adjusted to obtain high cellular viabilities. The co‐encapsulation of living cells provides i) an in vitro platform for the study of cellular metabolic processes which can be applied to bone formation and ii) an in vitro foundation for novel tissue‐regenerative therapies. Finally, the degradability of the microgels at physiological conditions caused by hydrolysis‐sensitive ester groups in the polymer network is examined.
536 _ _ |a 552 - Engineering Cell Function (POF3-552)
|0 G:(DE-HGF)POF3-552
|c POF3-552
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Kuzmina, Alena
|b 1
700 1 _ |a Beltramo, Guillermo L.
|0 P:(DE-Juel1)128800
|b 2
700 1 _ |a Koziol, Martha F.
|b 3
700 1 _ |a Besch, Laura
|b 4
700 1 _ |a Schröder, Romina
|b 5
700 1 _ |a Unger, Ronald E.
|0 0000-0003-2482-9705
|b 6
700 1 _ |a Tremel, Wolfgang
|b 7
700 1 _ |a Seiffert, Sebastian
|0 0000-0002-5152-1207
|b 8
|e Corresponding author
773 _ _ |a 10.1002/adhm.201901820
|g p. 1901820 -
|0 PERI:(DE-600)2645585-7
|n 11
|p 1901820
|t Advanced healthcare materials
|v 9
|y 2020
|x 2192-2659
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/875439/files/adhm.201901820.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://juser.fz-juelich.de/record/875439/files/adhm.201901820.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:875439
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)128800
913 1 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-552
|2 G:(DE-HGF)POF3-500
|v Engineering Cell Function
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ADV HEALTHC MATER : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b ADV HEALTHC MATER : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBI-2-20200312
|k IBI-2
|l Mechanobiologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBI-2-20200312
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21